Clorox – The consumer products giant posted strong profit growth. There is also a backlash from last year’s cyber attack. “Things are back online and there’s a huge demand for their products,” Jim said in rapid succession during Friday morning assembly. Tesla – EV leader announces recall of 2.2 million cars he has due to warning light issue. Remember, our Super 6 means eliminating Tesla. It’s no longer the Magnificent Seven. He said that maybe Jim shouldn’t buy a slide. “I would urge people to maybe reconsider that. [Elon Musk] Bristol-Myers Squibb – The company’s stock rose on strong earnings and a better-than-expected 2024 outlook. “It’s a five-year plan for Bristol-Myers,” Jim said. “The company could get more treatments. CNBC Investment Club members know Eli Lilly is our favorite drug stock. Abbvie – Pharma Posts Mixed Quarter Abbvie lost exclusivity on blockbuster Humira; stock price maintenance shows.” Exxon and Chevron – Two oil majors made profits, but Chevron paid dividends. The company increased its dividend due to rumors that it would not be able to pay the dividend, resulting in a 3% increase. , “If we have to own oil, we like Kotera” and own it for the club. He prefers Chevron to Exxon.
